GS Biopharmaceutical

BiotechnologySeries AShanghai, China

Latest round

Series A

Last raised

Nov 2024

Total raised

$14M

Investors

3

About GS Biopharmaceutical

Established in 2018 and based in Shanghai, China, GS Biopharmaceutical operates as a biopharmaceutical company that mainly provides photosensitizers and related products. It has a R&D center in Shanghai. The company's main business is the research, development and manufacturing of innovative photosensitizers and related products. The company's main product is an antitumor photosensitizer, "Sinoporphyrin sodium for injection". It also develops innovative photo or acoustic dynamic related devices for esophageal cancer, rectal cancer, and gliomas. The company generates revenue by providing innovative photosensitizers and related products.

Who invested in GS Biopharmaceutical

3 investors across 2 rounds

See all investors in GS Biopharmaceutical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 26, 2024

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Feb 28, 2024

    Amount

    $14M

    Investors

    Locked

Questions about GS Biopharmaceutical

Who invested in GS Biopharmaceutical?

GS Biopharmaceutical has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GS Biopharmaceutical raised?

GS Biopharmaceutical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did GS Biopharmaceutical last raise money?

GS Biopharmaceutical's most recent round on record is a Series A, in Nov 2024.

What does GS Biopharmaceutical do?

Established in 2018 and based in Shanghai, China, GS Biopharmaceutical operates as a biopharmaceutical company that mainly provides photosensitizers and related products.

Where is GS Biopharmaceutical headquartered?

GS Biopharmaceutical is headquartered in Shanghai, China.

Which VCs invest in companies like GS Biopharmaceutical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GS Biopharmaceutical's stage. Their profiles are linked below.

Raising like GS Biopharmaceutical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.